PLSE PULSE BIOSCIENCES, INC.

8-K Current Report

Filed: March 12, 2026

Health Care

Surgical & Medical Instruments & Apparatus

PULSE BIOSCIENCES, INC. (PLSE) 8-K current report filed with SEC EDGAR on March 12, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 8.01: Other Events

AI Filing Analysis
8-K

Item 8.01 · Other Events

• First patients enrolled in IDE study of Vybrance™ System for papillary thyroid microcarcinoma, targeting tumors <1.5cm
• Multicenter feasibility study across Sarasota Memorial and UT MD Anderson; 30 patients planned for enrollment

+3 more insights

Other PULSE BIOSCIENCES, INC. 8-K Filings

Get deeper insights on PULSE BIOSCIENCES, INC.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.